Table 1.

Demographic and clinical characteristics of all patients

	All patients (n = 84)
Men–women, n	37–47
Age, y	58.1 ± 12.4 (28–86)
Age of onset, y	44.0 ± 16.9 (0–80)
Disease duration, y	14.1 ± 12.5 (1–72)
Diagnosis
-Inherited	69 (82%)
-Sporadic	7 (8.5%)
-Acquired	1 (1%)
-Unknown	7 (8.5%)
Disease stage (self-reported) [47]
-Stage 0 (no gait difficulties)	10 (12%)
-Stage 1 (onset gait difficulties)	29 (34.5%)
-Stage 2 (loss independent gait)	37 (44%)
-Stage 3 (confinement to wheelchair)	8 (9.5%)
Any comorbidity	28 (33%)
Drug use	51 (61%)
Neurotropic drug use	30 (36%)
-Use of anticholinergics/benzodiazepines	8 (10%)
Education level [48]	5.6 ± 1.1 (1–7)
Subjective cognitive complaints	24 (29%)
-Executive functioning	14 (17%)
-Memory and attention	19 (23%)

Continuous variables are presented as means ± SDs (ranges), ordinal variables as frequencies